Pharmacokinetic Interaction between Nifedipine and Paclitaxel in Rats |
최준식
(조선대학교 약학대학)
이종기 (초당대학교 의약관리학부) |
1 |
Phase Ⅱ trial of taxol in patients with metastatic renal cell carcinoma
/
DOI ScienceOn |
2 |
Short communication; Taxol metabolism in rat hepatocytes
/
DOI ScienceOn |
3 |
Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and relatd cardiovascular disorders
/
DOI ScienceOn |
4 |
Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells
/
DOI ScienceOn |
5 |
Oxidation of dihydro-pyridine calcium channel blockers and analogues by human liver cytochrome P-450 ⅢA4
/
|
6 |
Sequences of taxol and cisplatin: A Phase I and pharmacologic study
/
DOI |
7 |
Phase I trial of taxol in patients with advanced malignancies
/
|
8 |
Phase I trial of taxol given as a 24-hour infusion every 21 days: Responses seen in metastatic melanoma
/
DOI |
9 |
Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics
/
DOI |
10 |
LAGRAN program for area and monents in pharmacokinetic analysis
/
DOI ScienceOn |
11 |
Phase Ⅱ study and long-term follow up of patients treated with taxol for advanced ovarian adenocarcinoma
/
DOI |
12 |
Phase I study of taxol and granulocyte stimulation factor in patients with refractory ovarian cancer
/
DOI |
13 |
Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial(Caco-2) cells
/
DOI ScienceOn |
14 |
Clinical Pharma-cokinetics of paclitaxel
/
DOI ScienceOn |
15 |
Effects of intestinal CYP3A4 and P-glycoprotein on oral drug absorption-theoretical approach
/
DOI ScienceOn |
16 |
A phase Ⅱ study of taxol in patients with malignant melanoma
/
|
17 |
Phase Ⅱ trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer
/
DOI ScienceOn |
18 |
Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem
/
DOI ScienceOn |
19 |
Selective biotransformation of taxol to 6α-hydroxytaxol by human cytochrome P450 2C8
/
|
20 |
Effects of verapamail on the acute toxicity of doxorubicin in vivo
/
DOI |
21 |
Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasm.
/
DOI ScienceOn |
22 |
Phase I study of taxol administered as a short iv infusion daily for 5 days
/
|
23 |
Modulation by verapamil of vincristine pharmacokinetics and toxicity in mice bearing human tumor xenografts
/
DOI ScienceOn |
24 |
Assay of paclitaxel (Taxol) in plasma and urine by high performance liquid chromatogrphy
/
DOI |
25 |
Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme.
/
|
26 |
Determination of new anticancer drug, paclitaxel, in biological fluids by high performance liquid chromatography
/
DOI |
27 |
Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers
/
|
28 |
The barrier function of CYP3A4 and Pglycoprotein in the small bowel.
/
DOI |
29 |
Variability in human cytochrome P450 paclitaxel metabolism
/
|
30 |
Phase I study of taxol using a 50day intermittent schedule
/
DOI |